Search

everythinglearnresearchcommunity

for

Search:↓

Up to 10% of hair loss patients might have early signs of a condition called Lichen Planopilaris.

Scarring alopecias are complex hair loss disorders that require early treatment to prevent permanent hair loss.

Lichen planopilaris can be accurately diagnosed and effectively treated.

Effective alopecia treatment depends on the specific cause and includes medications and procedures.

The study concluded that people with Lichen Planopilaris have a more diverse scalp bacteria and different metabolic pathways compared to healthy individuals.

Patients with Lichen Planopilaris are more likely to have rosacea and skin cancer but less likely to have congestive heart failure, stroke, and glaucoma.

A 66-year-old woman experienced hair loss due to Frontal Fibrosing Alopecia, a condition with no consistently effective treatment, but it usually stabilizes over time. More research is needed for better understanding and treatment options.

A mother and daughter with similar hair loss conditions and identical HLA types suggest a genetic link between the conditions.

New treatments for Frontal Fibrosing Alopecia show promise, especially finasteride and dutasteride, with most patients seeing improvement or stabilization.

A 12-year-old boy's hair loss and skin issues improved significantly with medication.

Fibrosing alopecia in a pattern distribution is a new type of scarring hair loss that resembles common baldness and an autoimmune skin disease.

A 66-year-old man with a rare case of male frontal fibrosing alopecia did not regrow hair despite treatment.

Japanese cases of fibrosing alopecia show a unique age and hair loss pattern, possibly due to racial differences.

Lichen planopilaris causes permanent hair loss and scarring due to damage to hair follicles and can be mistaken for other hair loss conditions.

Frontal Fibrosing Alopecia is a hair loss condition mainly affecting postmenopausal women, with unclear causes and various clinical patterns.

Dermatoscopy helps diagnose hair and scalp disorders in people with Afro-textured hair, but more research is needed for better understanding and treatment.

Triple therapy with clobetasol, hydroxychloroquine, and N-acetylcysteine is recommended for better outcomes in treating lichen planopilaris.

PPAR-γ helps control skin oil glands and inflammation, and its disruption can cause hair loss diseases.

Etanercept may cause lichen planopilaris, so doctors should be cautious.

Stress may trigger hair loss by affecting immune protection in hair follicles.

Lichen planopilaris in men often involves scalp redness and itching, with some also having hair loss, mucosal lichen planus, or thyroid disease, and treatment improved symptoms in nearly half of the cases.

The document highlights advancements and findings in dermatology, including AI use, disease prevention, treatment efficacy, and the impact of conditions on patients' lives.

Some cases of folliculotropic mycosis fungoides may progress slowly and not need aggressive treatment.

The document concludes that post-menopausal frontal fibrosing alopecia is a poorly understood condition that does not respond well to common treatments.

Mitochondrial dysfunction may contribute to chronic inflammation and immune system issues in Lichen planopilaris.

Platelet-rich plasma (PRP) is an effective treatment for lichen planopilaris.

A 62-year-old woman with hair loss and scalp itching was diagnosed with lichen planopilaris, treated initially with topical corticosteroids, and other possible treatments include systemic steroids, antimalarials, and more.

New hair treatment methods are evolving, with microneedling as a promising technique for hair growth.

Accurate early diagnosis of Lichen Planopilaris is crucial to prevent permanent hair loss.

Using CD123 to detect certain immune cells helps diagnose a type of hair loss condition.